COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.
about
Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisInsights into gastric neuroendocrine tumors burdenAbnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis.HuR: a promising therapeutic target for angiogenesisCyclooxygenase- and lipoxygenase-mediated DNA damage.Increased level of serum prostaglandin-2 in early stage of esophageal squamous cell carcinoma.Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsThe function and mechanism of COX-2 in angiogenesis of gastric cancer cells.Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Podocalyxin as a Prognostic Marker in Gastric CancerCyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han populationIdentification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.Cyclooxygenase-2 and gastric cancer.Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.Role of cyclooxygenase-2 in gastric cancer development and progression.Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry.Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression.Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.Interleukin polymorphisms and differential methylation status in gastric cancer: an association with Helicobacter pylori infection.Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer.Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study.
P2860
Q28290458-39BF3E81-926E-44F3-8A57-65F3729CEA5DQ33649959-4DC0C43E-FECC-4872-9695-EF337A6A2CF4Q33852902-320D4970-7732-489A-9639-AD3631E511B8Q34070037-96CEAA5B-557A-4D56-8F9F-D943B0B3349FQ34225293-7321ADE6-4D9C-44E4-B507-781705569D9EQ34466680-1545E8E7-964B-4752-B43F-972FE19B7D83Q34491276-890B8EE1-5062-4640-A719-3D40F46CE5F4Q34576784-8CA4DCAF-4761-4FE0-993B-7638C547058CQ35037270-C6D037DD-F51C-4FEC-B361-F23ACDC5D053Q35870705-1A662E1C-0914-4DF7-8595-43FDD5E06FA8Q36297035-F1929F1A-D275-45FC-ABEB-AACC28D5302EQ36539497-CD3B64E8-F9FA-4DAF-B922-E8DFCD9C0C94Q37946290-6FAFFB21-8246-44E3-8EED-629146AE4C59Q38157778-5ED40E0F-D486-47C8-9866-82B50AAB52DCQ38164703-DCC8641A-CB7E-4061-8D02-92AAF0F771B5Q38222606-BBCB0F14-C9AF-41D2-A221-92C4DE011E22Q39377146-E6D3E087-290A-496B-935E-5A1CC30016FBQ41093177-9059CC81-387D-4A3B-9810-74FF022BE389Q44514407-D7614196-987D-4146-B439-263A69C679C6Q49486938-8DA47940-B0BB-4821-8874-62B36EB2CC8DQ54563722-C29F2630-FA1E-4ADF-AE31-D7A383850A26
P2860
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
COX-2 is associated with proli ...... stic factor in gastric cancer.
@en
type
label
COX-2 is associated with proli ...... stic factor in gastric cancer.
@en
prefLabel
COX-2 is associated with proli ...... stic factor in gastric cancer.
@en
P2093
P1433
P1476
COX-2 is associated with proli ...... stic factor in gastric cancer.
@en
P2093
Ari Ristimäki
Arto Kokkola
Caj Haglund
Jan-Patrik Wiksten
Johanna Mrena
Stig Nordling
P2888
P356
10.1007/S13277-009-0001-4
P577
2009-12-18T00:00:00Z
P6179
1000586054